In the world of medicine, few events manage to combine science, technology, and creativity as effectively as the launch of this innovative AstraZeneca medication. Our agency had the honor of developing this event comprehensively, from creating the concept and visual identity to designing immersive technological experiences.

From the outset, our goal was to convey how this medication can transform people’s lives, allowing them to live normally. We designed a visual identity that captured this promise, infusing every element of the event with a sense of hope and progress.

The creative script for the event was a central piece, developed to guide participants through a narrative that combined detailed information about the medication with moments of discovery and interaction. This approach allowed more than 400 doctors from around the world not only to learn about the product but also to experience its potential impact in a tangible and emotional way.

To make the event truly unique, we incorporated various technological and sensory experiences. Participants interacted with digital installations, 3D scientific visualizations, and engaged in activities that illustrated the medication’s mechanisms of action in an educational and playful manner.

Attendees gained a deeper understanding of the treatment and left with an enriching and memorable experience. The combination of creative art direction and the development of advanced technologies allowed medical information to be presented in an accessible and engaging way.

Our collaboration with AstraZeneca for this launch demonstrated the power of creativity and technology to transform scientific events into unforgettable experiences, standing out for their ability to inspire medical professionals and effectively communicate the benefits of a crucial advancement in the treatment of rare diseases.